McKesson Corporation (NYSE:MCK) Files An 8-K Other Events

Item8.01

On December21, 2016, McKesson Corporation (the Company) and
Change Healthcare Holdings, Inc. (Change Healthcare) issued a
press release announcing that the Company had received
notification that the Department of Justice closed its review and
terminated the waiting period under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, in connection
with the entry into a contribution and sale agreement, dated as
of June28, 2016, by and among the Company, Change Healthcare,
Inc., a Delaware corporation and indirect parent company of
Change Healthcare, and other affiliated parties to form a
healthcare information technology company. A copy of the press
release is attached hereto as Exhibit99.1 and is incorporated
herein by reference.

(d) Exhibits.

About McKesson Corporation (NYSE:MCK)

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

McKesson Corporation (NYSE:MCK) Recent Trading Information

McKesson Corporation (NYSE:MCK) closed its last trading session 00.00 at 141.13 with 1,603,830 shares trading hands.